Decline in Prostate Cancer Screenings Due to COVID-19

Posted On: 10/1/2020 2:17 PM

Christopher Pieczonka, Urologist and Director of Clinical Research of AMP talks about his concern about the decline in prostate cancer screenings due to COVID-19

Click here to read the article or listen to the segment

A.M.P. News

Virtual Men's Health Seminar with Dr. Daniel Welchons

Join us for a Virtual Men's Health Seminar with Dr. Daniel Welchons! Dr. Welchons will be discussing treatment options for managing symptoms related to benign prostatic hyperplasia (BPH) including the UroLift System. REGISTER HERE Read More...
March 30th is National Doctors' Day!

National Doctors Day honors the professionals for their dedication and contributions to society and the community. This is a chance for us to say “thank you” to our physicians for all that they do for us and our loved ones. #NationalDoctorsDay Read More...
PCR Testing available for patients with recurrent or complex urinary tract infections!

AMP is excited to offer PCR testing for patients with recurrent or complex urinary tract infections! PCR uses state-of-the-art technology to more accurately detect most urinary pathogens. Provides higher sensitivity and faster turn-around times (usually within 6 hours) compared to standard urine culture Provides resistance gene information to ensure patients receive the proper treatment The test is covered by Medicare and most commercial payers For more information, visit P4 Diagnostics webs Read More...